$EPR
EPR Properties Stock $epr

$epr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000104545024000027 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$167.2M	$172.0M	$705.7M
YoY Change	-2.43%	-3.76%	7.24%
Cost Of Revenue	$14.92M	$8.204M	$31.19M
YoY Change	97.49%	12.58%	1.2%
Gross Profit	$152.3M	$163.8M	$674.5M
YoY Change	-7.04%	-4.46%	7.54%
Gross Profit Margin	91.08%	95.23%	95.58%
Selling, General & Admin	$13.91M	$20.72M	$84.29M
YoY Change	-33.24%	0.91%	3.7%
% of Gross Profit	9.13%	12.65%	12.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$40.47M	$40.69M	$159.3M
YoY Change	1.17%	-1.48%	0.31%
% of Gross Profit	26.57%	24.85%	23.62%
Operating Expenses	$67.35M	$74.95M	$297.1M
YoY Change	-5.12%	7.78%	6.58%
Operating Profit	$84.96M	$88.82M	$306.4M
YoY Change	-7.36%	-12.81%	-1.47%
Interest Expense	-$35.28M	-$35.04M	$124.9M
YoY Change	-211.21%	-1.13%	-4.82%
% of Operating Profit	-41.52%	-39.45%	40.75%
Other Income/Expense, Net	$12.98M		$44.77M
YoY Change	44.98%		32.43%
Pretax Income	$63.06M	$46.20M	$174.8M
YoY Change	8.72%	8.91%	-1.52%
Income Tax	$347.0K	$667.0K	$1.727M
% Of Pretax Income	0.55%	1.44%	0.99%
Net Earnings	$56.68M	$39.49M	$173.0M
YoY Change	-1.7%	8.82%	-1.81%
Net Earnings / Revenue	33.89%	22.96%	24.52%
Basic Earnings Per Share	$0.75		$1.98
Diluted Earnings Per Share	$0.75	$0.52	$1.97
COMMON SHARES
Basic Shares Outstanding	75.68M shares	75.33M shares	75.26M shares
Diluted Shares Outstanding	75.71M shares		75.72M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$59.48M	$78.08M	$78.08M
YoY Change	-38.33%	-27.66%	-27.66%
Cash & Equivalents	$59.48M	$78.08M	$78.08M
Short-Term Investments
Other Short-Term Assets	$30.09M	$22.72M	$22.72M
YoY Change	-22.42%	-32.3%	-32.3%
Inventory
Prepaid Expenses
Receivables	$69.41M	$63.66M	$63.66M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$128.9M	$164.5M	$164.5M
YoY Change	-30.64%	-15.7%	-15.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.869B	$4.875B	$4.875B
YoY Change	-2.84%	-2.71%	-2.71%
Goodwill		$693.0K
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments	$46.13M	$49.75M	$49.75M
YoY Change	-9.52%	-6.06%	-6.06%
Other Assets	$2.929M	$2.902M	$2.902M
YoY Change	12.7%	12.61%	12.61%
Total Long-Term Assets	$5.565B	$5.536B	$5.536B
YoY Change	-0.1%	-0.49%	-0.49%
TOTAL ASSETS
Total Short-Term Assets	$128.9M	$164.5M	$164.5M
Total Long-Term Assets	$5.565B	$5.536B	$5.536B
Total Assets	$5.694B	$5.701B	$5.701B
YoY Change	-1.09%	-1.0%	-1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$84.15M	$94.93M	$94.93M
YoY Change	10.37%	18.53%	18.53%
Accrued Expenses	$223.1M	$227.0M	$227.0M
YoY Change	-6.31%	-5.98%	-5.98%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$336.2M	$353.2M	$353.2M
YoY Change	-1.76%	1.22%	1.22%
LONG-TERM LIABILITIES
Long-Term Debt	$2.818B	$2.816B	$2.816B
YoY Change	0.22%	0.21%	0.21%
Other Long-Term Liabilities	$91.83M	$77.44M	$77.44M
YoY Change	28.25%	21.12%	21.12%
Total Long-Term Liabilities	$2.910B	$2.894B	$2.894B
YoY Change	0.91%	0.68%	0.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$336.2M	$353.2M	$353.2M
Total Long-Term Liabilities	$2.910B	$2.894B	$2.894B
Total Liabilities	$3.246B	$3.247B	$3.247B
YoY Change	0.63%	0.74%	0.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$835.0K	$829.0K
YoY Change	0.72%	0.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$285.4M	$274.0M
YoY Change	4.2%	1.59%
Treasury Stock Shares
Shareholders Equity	$2.448B	$2.454B	$2.454B
YoY Change
Total Liabilities & Shareholders Equity	$5.694B	$5.701B	$5.701B
YoY Change	-1.09%	-1.0%	-1.0%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$56.68M	$39.49M	$173.0M
YoY Change	-1.7%	8.82%	-1.81%
Depreciation, Depletion And Amortization	$40.47M	$40.69M	$159.3M
YoY Change	1.17%	-1.48%	0.31%
Cash From Operating Activities	$99.54M	$77.00M	$447.1M
YoY Change	-18.09%	-16.34%	1.22%
INVESTING ACTIVITIES
Capital Expenditures	$75.10M	$43.13M	$269.4M
YoY Change	22.36%	150.58%	7.67%
Acquisitions
YoY Change
Other Investing Activities	$36.55M	-$60.89M	-$49.19M
YoY Change	-28217.69%	-2.9%	-51.46%
Cash From Investing Activities	-$38.55M	-$104.0M	-$201.0M
YoY Change	-37.33%	30.15%	-42.82%
FINANCING ACTIVITIES
Cash Dividend Paid	$68.24M		$272.2M
YoY Change	0.37%		2.48%
Common Stock Issuance & Retirement, Net			$3.081M
YoY Change			-11.95%
Debt Paid & Issued, Net			$0.00
YoY Change
Cash From Financing Activities	-$79.48M	-67.97M	-$275.7M
YoY Change	11.19%	0.43%	2.34%
NET CHANGE
Cash From Operating Activities	$99.54M	77.00M	$447.1M
Cash From Investing Activities	-$38.55M	-104.0M	-$201.0M
Cash From Financing Activities	-$79.48M	-67.97M	-$275.7M
Net Change In Cash	-$18.58M	-94.98M	-$29.53M
YoY Change	61.9%	70.96%	-83.54%
FREE CASH FLOW
Cash From Operating Activities	$99.54M	$77.00M	$447.1M
Capital Expenditures	$75.10M	$43.13M	$269.4M
Free Cash Flow	$24.44M	$33.88M	$177.7M
YoY Change	-59.37%	-54.73%	-7.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Dividends Dividends	243757000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2535719000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2535719000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001045450
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	75680966	shares
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3541869209	usd
CY2021	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2023	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2022	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2021	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2023	us-gaap	Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2023#UnrealizedGainLossOnDerivatives
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-13561
CY2023	dei	Entity Registrant Name EntityRegistrantName	EPR PROPERTIES
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	43-1790877
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	909 Walnut Street,
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kansas City,
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	MO
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	64106
CY2023	dei	City Area Code CityAreaCode	(816)
CY2023	dei	Local Phone Number LocalPhoneNumber	472-1700
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3541869209	usd
CY2023	dei	Auditor Name AuditorName	KPMG, LLP
CY2023	dei	Auditor Location AuditorLocation	Kansas City, Missouri
CY2023Q4	us-gaap	Real Estate Owned Accumulated Depreciation RealEstateOwnedAccumulatedDepreciation	1435683000	usd
CY2022Q4	us-gaap	Real Estate Owned Accumulated Depreciation RealEstateOwnedAccumulatedDepreciation	1302640000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4537359000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4714136000	usd
CY2023Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	20168000	usd
CY2022Q4	us-gaap	Land Available For Development LandAvailableForDevelopment	20168000	usd
CY2023Q4	us-gaap	Development In Process DevelopmentInProcess	131265000	usd
CY2022Q4	us-gaap	Development In Process DevelopmentInProcess	76029000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	186628000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	200985000	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	569768000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	457268000	usd
CY2023Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	49754000	usd
CY2022Q4	us-gaap	Real Estate Investments Joint Ventures RealEstateInvestmentsJointVentures	52964000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78079000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107934000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2902000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2577000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	63655000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	53587000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	61307000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	73053000	usd
CY2023Q4	us-gaap	Assets Assets	5700885000	usd
CY2022Q4	us-gaap	Assets Assets	5758701000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	94927000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	80087000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	226961000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	241407000	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	25275000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	21405000	usd
CY2023Q4	epr	Preferred Dividends Payable Current And Noncurrent PreferredDividendsPayableCurrentAndNoncurrent	6032000	usd
CY2022Q4	epr	Preferred Dividends Payable Current And Noncurrent PreferredDividendsPayableCurrentAndNoncurrent	6033000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	77440000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	63939000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2816095000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2810111000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	3246730000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3222982000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82964231	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82545501	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	829000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	825000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3924467000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3899732000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	7631725	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	7520227	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	274038000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	269751000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3296000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1897000	usd
CY2023Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1200547000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1097132000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2454155000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2535719000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5700885000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5758701000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	616139000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	575601000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	478882000	usd
CY2023	us-gaap	Other Income OtherIncome	45947000	usd
CY2022	us-gaap	Other Income OtherIncome	47382000	usd
CY2021	us-gaap	Other Income OtherIncome	18816000	usd
CY2023	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	43582000	usd
CY2022	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	35048000	usd
CY2021	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	33982000	usd
CY2022	us-gaap	Revenues Revenues	658031000	usd
CY2021	us-gaap	Revenues Revenues	531680000	usd
CY2021	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	56739000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	547000	usd
CY2023	epr	Transaction Costs TransactionCosts	1554000	usd
CY2022	epr	Transaction Costs TransactionCosts	4533000	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	878000	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	10816000	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-21972000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	67366000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27349000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2711000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168033000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163652000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163770000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	397072000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	347723000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	270753000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2197000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	651000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	17881000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	306399000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	310959000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	278808000	usd
CY2023	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	25451000	usd
CY2023	us-gaap	Interest Expense InterestExpense	124858000	usd
CY2022	us-gaap	Interest Expense InterestExpense	131175000	usd
CY2021	us-gaap	Interest Expense InterestExpense	148095000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6768000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1672000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5059000	usd
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	647000	usd
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	174773000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	177465000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	100203000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1727000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1236000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1597000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	173046000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	176229000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	98606000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24145000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24141000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24134000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	148901000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	152088000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74472000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.97
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.03
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75260000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74967000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74755000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75715000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75043000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74756000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	173046000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	176229000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	98606000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6851000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20474000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	633000	usd
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-5452000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	12416000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	5857000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	174445000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	168171000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	105096000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2630585000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	2901000	usd
CY2021	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	2763000	usd
CY2021	epr	Employee Service Share Based Compensation Restricted Stock Units And Restricted Shares Unrecognized Compensation Cost On Nonvested Awards EmployeeServiceShareBasedCompensationRestrictedStockUnitsAndRestrictedSharesUnrecognizedCompensationCostOnNonvestedAwards	14903000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	633000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	5857000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	3249000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	98606000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	569000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.50
CY2021	us-gaap	Dividends Dividends	112209000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2618039000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	4416000	usd
CY2022	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	4257000	usd
CY2022	epr	Employee Service Share Based Compensation Restricted Stock Units And Restricted Shares Unrecognized Compensation Cost On Nonvested Awards EmployeeServiceShareBasedCompensationRestrictedStockUnitsAndRestrictedSharesUnrecognizedCompensationCostOnNonvestedAwards	16666000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-20474000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	12416000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	176229000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1063000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	107000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.25
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	3.30
CY2023	us-gaap	Dividends Dividends	248530000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2454155000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	173046000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	176229000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	98606000	usd
CY2023	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	67366000	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	27349000	usd
CY2021	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	2711000	usd
CY2023	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	usd
CY2022	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	647000	usd
CY2021	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	0	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2197000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	651000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	17881000	usd
CY2023	epr	Gain On Insurance Recovery GainOnInsuranceRecovery	0	usd
CY2022	epr	Gain On Insurance Recovery GainOnInsuranceRecovery	552000	usd
CY2021	epr	Gain On Insurance Recovery GainOnInsuranceRecovery	1181000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-344000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-169000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	878000	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	10816000	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-21972000	usd
CY2023	epr	Write Off Of Deferred Debt Issuance Cost Continuing And Discontinued WriteOffOfDeferredDebtIssuanceCostContinuingAndDiscontinued	0	usd
CY2022	epr	Write Off Of Deferred Debt Issuance Cost Continuing And Discontinued WriteOffOfDeferredDebtIssuanceCostContinuingAndDiscontinued	0	usd
CY2021	epr	Write Off Of Deferred Debt Issuance Cost Continuing And Discontinued WriteOffOfDeferredDebtIssuanceCostContinuingAndDiscontinued	25451000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6768000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1672000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5059000	usd
CY2023	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	1300000	usd
CY2022	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	780000	usd
CY2021	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	90000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168033000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163652000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163770000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8637000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8360000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	7666000	usd
CY2023	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-535000	usd
CY2022	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-355000	usd
CY2021	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-385000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	17512000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	16666000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	14903000	usd
CY2023	epr	Sharebasedcompensationincludedinseveranceexpense Sharebasedcompensationincludedinseveranceexpense	304000	usd
CY2022	epr	Sharebasedcompensationincludedinseveranceexpense Sharebasedcompensationincludedinseveranceexpense	0	usd
CY2021	epr	Sharebasedcompensationincludedinseveranceexpense Sharebasedcompensationincludedinseveranceexpense	0	usd
CY2023	epr	Increase Decreasein Operating Lease Assetsand Liabilities Net IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet	-6000	usd
CY2022	epr	Increase Decreasein Operating Lease Assetsand Liabilities Net IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet	463000	usd
CY2021	epr	Increase Decreasein Operating Lease Assetsand Liabilities Net IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet	-551000	usd
CY2023	epr	Increase Decrease In Mortgage Notes Accrued Interest Receivable IncreaseDecreaseInMortgageNotesAccruedInterestReceivable	1231000	usd
CY2022	epr	Increase Decrease In Mortgage Notes Accrued Interest Receivable IncreaseDecreaseInMortgageNotesAccruedInterestReceivable	500000	usd
CY2021	epr	Increase Decrease In Mortgage Notes Accrued Interest Receivable IncreaseDecreaseInMortgageNotesAccruedInterestReceivable	-568000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10091000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25974000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-36821000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2738000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	473000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1282000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8488000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14576000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8653000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7510000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2768000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3185000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	447094000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	441716000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	306925000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	60703000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	174533000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	56556000	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	57160000	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	10965000	usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	96137000	usd
CY2023	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	4859000	usd
CY2022	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	26088000	usd
CY2021	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	13611000	usd
CY2023	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2022	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	6695000	usd
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2023	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	-10022000	usd
CY2022	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	3830000	usd
CY2021	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	usd
CY2023	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	110428000	usd
CY2022	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	95234000	usd
CY2021	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	8664000	usd
CY2023	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	552000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	1749000	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	8242000	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	3025000	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	4379000	usd
CY2023	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	1386000	usd
CY2022	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	701000	usd
CY2021	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	8816000	usd
CY2023	epr	Proceeds From Insurance Recovery ProceedsFromInsuranceRecovery	0	usd
CY2022	epr	Proceeds From Insurance Recovery ProceedsFromInsuranceRecovery	3700000	usd
CY2021	epr	Proceeds From Insurance Recovery ProceedsFromInsuranceRecovery	1181000	usd
CY2023	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	91153000	usd
CY2022	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	75710000	usd
CY2021	us-gaap	Payments To Develop Real Estate Assets PaymentsToDevelopRealEstateAssets	29304000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-201048000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-351585000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1862000	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	400000000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1288765000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	369000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	328000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	15212000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-22865000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	615000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	758000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	460000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2000	usd
CY2023	epr	Issuances Of Captive Reit Preferred Shares IssuancesOfCaptiveREITPreferredShares	0	usd
CY2022	epr	Issuances Of Captive Reit Preferred Shares IssuancesOfCaptiveREITPreferredShares	107000	usd
CY2021	epr	Issuances Of Captive Reit Preferred Shares IssuancesOfCaptiveREITPreferredShares	0	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3696000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4257000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2763000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	272245000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	265661000	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	117531000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-275695000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-269392000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1046678000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-129000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-218000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-29530000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-179390000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-738109000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110511000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289901000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1028010000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80981000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110511000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289901000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107934000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288822000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1025577000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2577000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1079000	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2433000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110511000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289901000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1028010000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78079000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	107934000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	288822000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2902000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2577000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1079000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80981000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110511000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	289901000	usd
CY2023	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	44291000	usd
CY2022	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	41872000	usd
CY2021	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	91546000	usd
CY2023	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	1321000	usd
CY2022	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	0	usd
CY2021	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate		usd
CY2023	epr	Issuance Of Restricted Securities To Employees And Directors IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors	25277000	usd
CY2022	epr	Issuance Of Restricted Securities To Employees And Directors IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors	21751000	usd
CY2021	epr	Issuance Of Restricted Securities To Employees And Directors IssuanceOfRestrictedSecuritiesToEmployeesAndDirectors	21921000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	36741000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33355000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	125654000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	125808000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	150034000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1495000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1282000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1466000	usd
CY2023	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	3566000	usd
CY2022	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1286000	usd
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	1567000	usd
CY2023	epr	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	6466000	usd
CY2022	epr	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	896000	usd
CY2021	epr	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	2880000	usd
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset	12000000	usd
CY2023	epr	Collections Deferred Rent Cash Basis Tenants CollectionsDeferredRentCashBasisTenants	36400000	usd
CY2022	epr	Collections Deferred Rent Cash Basis Tenants CollectionsDeferredRentCashBasisTenants	17700000	usd
CY2023	epr	Collections Deferred Rent Accrual Basis Tenants CollectionsDeferredRentAccrualBasisTenants	2100000	usd
CY2022	epr	Collections Deferred Rent Accrual Basis Tenants CollectionsDeferredRentAccrualBasisTenants	24200000	usd
CY2023Q4	epr	Number Of Master Leases NumberOfMasterLeases	2	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP). Actual results could differ from those estimates.</span></div>
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36613000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32624000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	525000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	169000	usd
CY2023	epr	Current Incomeand Withholding Tax Expense CurrentIncomeandWithholdingTaxExpense	2100000	usd
CY2022	epr	Current Incomeand Withholding Tax Expense CurrentIncomeandWithholdingTaxExpense	1400000	usd
CY2021	epr	Current Incomeand Withholding Tax Expense CurrentIncomeandWithholdingTaxExpense	1600000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2000000000	usd
CY2023	epr	Transaction Costs TransactionCosts	1600000	usd
CY2022	epr	Transaction Costs TransactionCosts	4500000	usd
CY2021	epr	Transaction Costs TransactionCosts	3400000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	693000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	693000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	34710000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	36622000	usd
CY2023Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	3100000	usd
CY2022Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	2400000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	7557000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	7741000	usd
CY2023	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-500000	usd
CY2022	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-400000	usd
CY2021	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	-400000	usd
CY2023Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	49754000	usd
CY2022Q4	us-gaap	Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures	52964000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6768000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1672000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	600000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	25100000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	31100000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	epr	Number Of Theatres In Entertainment D Istricts NumberOfTheatresInEntertainmentDIstricts	7	segment
CY2023	epr	Straightlinerentwriteoff Straightlinerentwriteoff	700000	usd
CY2022	epr	Straightlinerentwriteoff Straightlinerentwriteoff	200000	usd
CY2021	epr	Straightlinerentwriteoff Straightlinerentwriteoff	200000	usd
CY2023	us-gaap	Straight Line Rent StraightLineRent	10600000	usd
CY2022	us-gaap	Straight Line Rent StraightLineRent	7000000	usd
CY2021	us-gaap	Straight Line Rent StraightLineRent	5700000	usd
CY2023	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	19600000	usd
CY2022	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	17200000	usd
CY2021	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	15200000	usd
CY2023	epr	Operating Lease Percentage Revenue OperatingLeasePercentageRevenue	12200000	usd
CY2022	epr	Operating Lease Percentage Revenue OperatingLeasePercentageRevenue	10500000	usd
CY2021	epr	Operating Lease Percentage Revenue OperatingLeasePercentageRevenue	14000000	usd
CY2022	epr	Variable Percentage Rent VariablePercentageRent	400000	usd
CY2021	epr	Variable Percentage Rent VariablePercentageRent	16200000	usd
CY2023	epr	Termination Fee TerminationFee	3400000	usd
CY2023Q4	epr	Number Of Terminated Properties NumberOfTerminatedProperties	2	properties
CY2023Q4	epr	Number Of Terminated Tenants NumberOfTerminatedTenants	2	tenant
CY2021	epr	Termination Fee TerminationFee	0	usd
CY2022	epr	Termination Fee TerminationFee	0	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	25134000	usd
CY2022	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	1500000	usd
CY2023	epr	Mortgage And Other Participating Interest Income MortgageAndOtherParticipatingInterestIncome	57000	usd
CY2022	epr	Mortgage And Other Participating Interest Income MortgageAndOtherParticipatingInterestIncome	0	usd
CY2021	epr	Mortgage And Other Participating Interest Income MortgageAndOtherParticipatingInterestIncome	0	usd
CY2023	epr	Percent Of Taxable Income Distributed To Shareholders Annually PercentOfTaxableIncomeDistributedToShareholdersAnnually	0.90
CY2023Q4	epr	Number Of Trs Entities NumberOfTRSEntities	4	properties
CY2023Q4	epr	Number Of Experiential Lodging Properties In Trs NumberOfExperientialLodgingPropertiesInTRS	5	properties
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11200000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	11200000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41700000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	36900000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4600000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	36600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32600000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	25416000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	22788000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11296000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10093000	usd
CY2023Q4	epr	Deferred Tax Asset Startup Costs DeferredTaxAssetStartupCosts	2301000	usd
CY2022Q4	epr	Deferred Tax Asset Startup Costs DeferredTaxAssetStartupCosts	2185000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2698000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1826000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41711000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	36892000	usd
CY2023Q4	epr	Deferred Tax Liabilities Capital Improvements DeferredTaxLiabilitiesCapitalImprovements	2786000	usd
CY2022Q4	epr	Deferred Tax Liabilities Capital Improvements DeferredTaxLiabilitiesCapitalImprovements	2718000	usd
CY2023Q4	epr	Deferred Tax Liabilities Straightline Rent Receivable DeferredTaxLiabilitiesStraightlineRentReceivable	982000	usd
CY2022Q4	epr	Deferred Tax Liabilities Straightline Rent Receivable DeferredTaxLiabilitiesStraightlineRentReceivable	962000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	805000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	419000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4573000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4099000	usd
CY2023	epr	Current Trs Tax Expensebenefit CurrentTRSTaxExpensebenefit	0	usd
CY2022	epr	Current Trs Tax Expensebenefit CurrentTRSTaxExpensebenefit	137000	usd
CY2021	epr	Current Trs Tax Expensebenefit CurrentTRSTaxExpensebenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	240000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	226000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	505000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	513000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	4000	usd
CY2023	epr	Current Foreign Withholding Tax Benefit CurrentForeignWithholdingTaxBenefit	1318000	usd
CY2022	epr	Current Foreign Withholding Tax Benefit CurrentForeignWithholdingTaxBenefit	1041000	usd
CY2021	epr	Current Foreign Withholding Tax Benefit CurrentForeignWithholdingTaxBenefit	1088000	usd
CY2023	epr	Deferred Trs Income Tax Expense Benefit DeferredTRSIncomeTaxExpenseBenefit	0	usd
CY2022	epr	Deferred Trs Income Tax Expense Benefit DeferredTRSIncomeTaxExpenseBenefit	0	usd
CY2021	epr	Deferred Trs Income Tax Expense Benefit DeferredTRSIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-344000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-169000	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1727000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1236000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1597000	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.008
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.021
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	epr	Provisionforincometaxexpense Provisionforincometaxexpense	0	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	31118000	usd
CY2023Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5973042000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	6016776000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1435683000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1302640000	usd
CY2023Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4537359000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4714136000	usd
CY2023	us-gaap	Depreciation Depreciation	159300000	usd
CY2022	us-gaap	Depreciation Depreciation	158800000	usd
CY2021	us-gaap	Depreciation Depreciation	158300000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	269400000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	402500000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	269428000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	402519000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	57200000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2200000	usd
CY2023Q4	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Carrying Value Of Asset ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleCarryingValueOfAsset	39200000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	67400000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	600000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2700000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2816095000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2810111000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1000000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	1000000000	usd
CY2023Q4	epr	Straight Line Rent Receivable StraightLineRentReceivable	55533000	usd
CY2022Q4	epr	Straight Line Rent Receivable StraightLineRentReceivable	44986000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	63655000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	53587000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	2100000	usd
CY2023Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Face Amount Asset FairValueDisclosureOffbalanceSheetRisksFaceAmountAsset	12000000	usd
CY2023Q4	srt	Mortgage Loans On Real Estate Face Amount Of Mortgages MortgageLoansOnRealEstateFaceAmountOfMortgages	569811000	usd
CY2023Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	569768000	usd
CY2022Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	457268000	usd
CY2023Q4	epr	Number Of Mortgage Notes Receivable NumberOfMortgageNotesReceivable	1
CY2023Q4	epr	Number Of Mortgage Notes Receivable NumberOfMortgageNotesReceivable	1
CY2023Q4	epr	Notes Receivable NotesReceivable	3900000	usd
CY2022Q4	epr	Notes Receivable NotesReceivable	2900000	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	10886000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	10816000	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	21702000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	878000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	8165000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	14415000	usd
CY2023Q4	epr	Swap Termination Extension Period SwapTerminationExtensionPeriod	2	segment
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	136637000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	300000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	629597000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	450000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	400000000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	924995000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	25134000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	2816095000	usd
CY2023	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	122968000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	123070000	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	138805000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8637000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8360000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	7666000	usd
CY2023	epr	Line Of Credit Facility And Letter Of Credit Fees LineOfCreditFacilityAndLetterOfCreditFees	2676000	usd
CY2022	epr	Line Of Credit Facility And Letter Of Credit Fees LineOfCreditFacilityAndLetterOfCreditFees	2682000	usd
CY2021	epr	Line Of Credit Facility And Letter Of Credit Fees LineOfCreditFacilityAndLetterOfCreditFees	3344000	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3566000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1286000	usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1567000	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	5857000	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	1651000	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	153000	usd
CY2023	us-gaap	Interest Expense InterestExpense	124858000	usd
CY2022	us-gaap	Interest Expense InterestExpense	131175000	usd
CY2021	us-gaap	Interest Expense InterestExpense	148095000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1300000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	11400000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4900000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2023Q4	epr	Swap Termination Extension Period SwapTerminationExtensionPeriod	2	segment
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3924000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	12788000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3561000	usd
CY2023	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	1528000	usd
CY2022	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	372000	usd
CY2021	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	-9418000	usd
CY2023	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	0	usd
CY2022	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	170000	usd
CY2021	us-gaap	Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet	367000	usd
CY2023	us-gaap	Interest Expense InterestExpense	124858000	usd
CY2022	us-gaap	Interest Expense InterestExpense	131175000	usd
CY2021	us-gaap	Interest Expense InterestExpense	148095000	usd
CY2023	us-gaap	Other Income OtherIncome	45947000	usd
CY2022	us-gaap	Other Income OtherIncome	47382000	usd
CY2021	us-gaap	Other Income OtherIncome	18816000	usd
CY2021	us-gaap	Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet	3200000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4900000	usd
CY2023Q4	us-gaap	Derivative Liability After Offset Subject To Master Netting Arrangement DerivativeLiabilityAfterOffsetSubjectToMasterNettingArrangement	5000000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	67400000	usd
CY2023Q4	epr	Numberofimpairedproperties Numberofimpairedproperties	12	property
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27300000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	600000	usd
CY2023	epr	Shelfregistrationeffectiveterm Shelfregistrationeffectiveterm	3
CY2023	epr	Shelfregistrationeffectiveterm Shelfregistrationeffectiveterm	3
CY2023Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	25000000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	173046000	usd
CY2023	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	24145000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	148901000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75260000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.98
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	148901000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	75260000	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	455000	shares
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	148901000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75715000	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.97
CY2022	us-gaap	Net Income Loss NetIncomeLoss	176229000	usd
CY2022	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	24141000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	152088000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74967000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	152088000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74967000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	76000	shares
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	152088000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75043000	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.03
CY2021	us-gaap	Net Income Loss NetIncomeLoss	98606000	usd
CY2021	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	24134000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74472000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74755000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.00
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74472000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74755000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74472000	usd
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74756000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.00
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	503912	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	50.38
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	352090	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	42.23
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	232898	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	53.92
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	13876	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	45.18
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	609228	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	44.44
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y10M20D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	8700000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	10200000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	6600000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	10400000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	14000	usd
CY2021	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	17000	usd
CY2023	epr	Maximum Term Of Options Granted MaximumTermOfOptionsGranted	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	116690	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.36
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5051	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.27
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1838	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	44.44
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4806	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	51.42
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	108671	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	56.79
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	12559	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	46.43
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96112	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	58.15
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	14921	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	52.68
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	81191	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	59.16
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.34
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	62000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	14000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	12000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	81191	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M6D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	59.16
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	79551	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	59.23
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	518842000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	515314000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	512916000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	495012000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	484944000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	3425325000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	5952353000	usd
CY2023Q4	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	51
CY2022Q4	us-gaap	Number Of Properties Subject To Ground Leases NumberOfPropertiesSubjectToGroundLeases	52
CY2023Q4	epr	Number Of Tenants Ground Lease Subtenants Cash Basis NumberOfTenantsGroundLeaseSubtenantsCashBasis	2
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	186628000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	200985000	usd
CY2023Q4	epr	Total Operating Leased Assets TotalOperatingLeasedAssets	204058000	usd
CY2022Q4	epr	Total Operating Leased Assets TotalOperatingLeasedAssets	215571000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	226961000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	241407000	usd
CY2023Q4	epr	Number Of Mortgage Notes Receivable NumberOfMortgageNotesReceivable	5	mortgagenotes
CY2023Q4	epr	Mortgage Noteand Notes Receivable Commitments MortgageNoteandNotesReceivableCommitments	104700000	usd
CY2023Q4	epr	Numberof Surety Bonds NumberofSuretyBonds	3
CY2023Q4	epr	Suretybonds Suretybonds	2100000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q4	us-gaap	Assets Assets	5700885000	usd
CY2022Q4	us-gaap	Assets Assets	5758701000	usd
CY2023	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	616139000	usd
CY2023	us-gaap	Other Income OtherIncome	45947000	usd
CY2023	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	43582000	usd
CY2023	us-gaap	Revenues Revenues	705668000	usd
CY2023	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	57478000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	44774000	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	102252000	usd
CY2023	epr	Net Operating Income Before Unallocated Items NetOperatingIncomeBeforeUnallocatedItems	603416000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	56442000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	547000	usd
CY2023	epr	Transaction Costs TransactionCosts	1554000	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	878000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	67366000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	168033000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2197000	usd
CY2023	us-gaap	Interest Expense InterestExpense	124858000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6768000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1727000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	173046000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24145000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	148901000	usd
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	575601000	usd
CY2022	us-gaap	Other Income OtherIncome	47382000	usd
CY2022	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	35048000	usd
CY2022	us-gaap	Revenues Revenues	658031000	usd
CY2022	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	55985000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	33809000	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	89794000	usd
CY2022	epr	Net Operating Income Before Unallocated Items NetOperatingIncomeBeforeUnallocatedItems	568237000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51579000	usd
CY2022	epr	Transaction Costs TransactionCosts	4533000	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	10816000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	27349000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163652000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	651000	usd
CY2022	us-gaap	Interest Expense InterestExpense	131175000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1672000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	647000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1236000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	176229000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24141000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	152088000	usd
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	478882000	usd
CY2021	us-gaap	Other Income OtherIncome	18816000	usd
CY2021	us-gaap	Interest And Fee Income Loans Commercial And Residential Real Estate InterestAndFeeIncomeLoansCommercialAndResidentialRealEstate	33982000	usd
CY2021	us-gaap	Revenues Revenues	531680000	usd
CY2021	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	56739000	usd
CY2021	us-gaap	Other Expenses OtherExpenses	21741000	usd
CY2021	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	78480000	usd
CY2021	epr	Net Operating Income Before Unallocated Items NetOperatingIncomeBeforeUnallocatedItems	453200000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44362000	usd
CY2021	epr	Transaction Costs TransactionCosts	3402000	usd
CY2021	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-21972000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2711000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	163770000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	17881000	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	25451000	usd
CY2021	us-gaap	Interest Expense InterestExpense	148095000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5059000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1597000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	98606000	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24134000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	74472000	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	25134000	usd
CY2023Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	2816095000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	1390733000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	4369287000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements	364455000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	1371376000	usd
CY2023Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	4753099000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	6124475000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	1435683000	usd
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	6112973000	usd
CY2023	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	166716000	usd
CY2023	us-gaap	Real Estate Cost Of Real Estate Sold RealEstateCostOfRealEstateSold	68550000	usd
CY2023	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	86664000	usd
CY2023Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	6124475000	usd
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	1302640000	usd
CY2023	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	161662000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Real Estate Sold RealEstateAccumulatedDepreciationRealEstateSold	9321000	usd
CY2023	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	19298000	usd
CY2023Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	1435683000	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	185

Files In Submission

Name	View Source	Status
0001045450-24-000027-index-headers.html	Edgar Link	pending
0001045450-24-000027-index.html	Edgar Link	pending
0001045450-24-000027.txt	Edgar Link	pending
0001045450-24-000027-xbrl.zip	Edgar Link	pending
epr-20231231.htm	Edgar Link	pending
epr-20231231.xsd	Edgar Link	pending
epr-20231231_g1.jpg	Edgar Link	pending
exhibit102-1231202310xk.htm	Edgar Link	pending
exhibit21-123123x10k.htm	Edgar Link	pending
exhibit23-123123x10k.htm	Edgar Link	pending
exhibit311-1231x23x10k.htm	Edgar Link	pending
exhibit312-123123x10k.htm	Edgar Link	pending
exhibit321-123123x10k.htm	Edgar Link	pending
exhibit322-123123x10k.htm	Edgar Link	pending
exhibit412-123123x10k.htm	Edgar Link	pending
exhibit971-1231202310xk.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
epr-20231231_cal.xml	Edgar Link	unprocessable
epr-20231231_def.xml	Edgar Link	unprocessable
epr-20231231_lab.xml	Edgar Link	unprocessable
epr-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
epr-20231231_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EPR
EPR Properties Stock $epr

2024 Q1 Form 10-K Financial Statement

#000104545024000027 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EPR EPR Properties Stock $epr

2024 Q1 Form 10-K Financial Statement

#000104545024000027 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EPR
EPR Properties Stock $epr